0001576280-24-000092.txt : 20240416
0001576280-24-000092.hdr.sgml : 20240416
20240416183519
ACCESSION NUMBER: 0001576280-24-000092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240415
FILED AS OF DATE: 20240416
DATE AS OF CHANGE: 20240416
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saia John G.
CENTRAL INDEX KEY: 0001737840
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38683
FILM NUMBER: 24848996
MAIL ADDRESS:
STREET 1: C/O ACELRX PHARMACEUTICALS, INC.
STREET 2: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER NAME:
FORMER CONFORMED NAME: Saia John
DATE OF NAME CHANGE: 20180417
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Guardant Health, Inc.
CENTRAL INDEX KEY: 0001576280
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 454139254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3100 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: 855-698-8887
MAIL ADDRESS:
STREET 1: 3100 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
4
1
wk-form4_1713306910.xml
FORM 4
X0508
4
2024-04-15
0
0001576280
Guardant Health, Inc.
GH
0001737840
Saia John G.
3100 HANOVER STREET
PALO ALTO
CA
94304
0
1
0
0
Chief Legal Officer
0
Common Stock
2024-04-15
4
F
0
1108
17.06
D
20797
D
Common Stock
2024-04-15
4
M
0
7569
0
A
28366
D
Common Stock
2024-04-15
4
F
0
2701
17.06
D
25665
D
Restricted Stock Units
0
2024-04-15
4
M
0
7569
0
D
Common Stock
7569
15137
D
These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
The restricted stock units granted on August 8, 2022 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of April 15, 2022, and the remaining 75% annually during the three-year period thereafter.
Not applicable for Restricted Stock Units.
/s/ John G. Saia
2024-04-16